Skip to main content

FDA has approved another ustekinumab biosimilar (Wezlana) as being interchangeable for use in adults with plaque psorias

Nov 02, 2023 10:04 am
Social Author Name
Dr. John Cush
Tweet Content
FDA has approved another ustekinumab biosimilar (Wezlana) as being interchangeable for use in adults with plaque psoriasis, psoriatic arthritis, Crohn’s disease and ulcerative colitis. https://t.co/zbQKjmKgZh https://t.co/UuTDRgCBIV
Show on Archive Page
On
Display in Search Results
On
PDQ
Off